Bcl-2-related proteins, α-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas

Acta Dermato-Venereologica

Volumn 82, Issue 6, 2002, Pages 423-427

  Bozdogan, Önder ^b   Erkek, Emel ^a   Atasoy, Pinar ^b   Koçak, Mukadder ^b   Birol, Ahu ^b   Çaydere, Muzaffer ^b  

^a Neyzen Tevfik Sokak   (Turkey)

^b NONE

Author keywords

Amyloid; Apoptosis; Basal cell carcinoma; Bax; Bcl 2; Bcl x; Myofibroblast

Indexed keywords

ALPHA ACTIN; AMYLOID; GENE PRODUCT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

ADULT; AGED; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; BIOPSY; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; SKIN CARCINOGENESIS; STROMA; TUMOR CELL;

ACTINS; ADULT; AGED; AMYLOID; APOPTOSIS; BCL-X PROTEIN; CARCINOMA, BASAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS;

EID: 12244291894     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155502762064548     Document Type: Article

References (28)

1. Teraki Y, Shiohara T. Apoptosis and the skin. Eur J Dermatol 1999; 9: 413-426.
2. Isoherranen K, Sauroja I, Punnonen CJK. UV irradiation induces downregulation of bcl-2 expression in vitro and in vivo. Arch Dermatol Res 1999; 291: 212-216.
3. Leiter U, Schmid RM, Kaskel P, Peter RU, Krähn G. Antiapoptotic bcl-2 and bcl-xl in advanced malignant melanoma. Arch Dermatol Res 2000; 292: 225-232.
4. Chiodino C, Cesinaro AM, Ottani D, Fantini F, Giannetti A, Trentini GP, et al. Expression of the novel inhibitor of apoptosis surviving in normal and neoplastic skin. J Invest Dermatol 1999; 113: 415-418.
5. Leverkus M, Yaar M, Gilchrest BA. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 1997; 232: 255-262.
6. Wang WJ, Huang JY, Wong CK, Chang YT. A study of secondary cutaneous amyloidosis in basal cell carcinoma in Chinese patients: lack of correlation with bcl-2 and p53 protein expression. Arch Dermatol Res 2000; 292: 379-383.
7. Gordon PM, Cox NH, Paterson WD, Lawrence CM. Basal cell carcinoma: are early appointments justifiable? Br J Dermatol 2000; 142: 446-448.
8. Raskin CA. Apoptosis and cutaneous biology. J Am Acad Dermatol 1997; 36: 885-896.
9. Haake AR, Polakowska RR. Cell death by apoptosis in epidermal biology. J Invest Dermatol 1993; 101: 107-112.
10. Solanki RL, Arora HL, Anand VK, Gaur SK, Gupta R. Amyloid and amyloid-like deposits in basal cell epithelioma. Indian J Med Res 1988; 88: 291-294.
11. Rippey JJ. Why classify basal cell carcinomas? Histopathology 1998; 12: 393-398.
12. Christian MM, Moy RL, Wagner RF, Yen-Moore A. A correlation of α smooth muscle actin and invasion in micronodular basal cell carcinoma. Dermatol Surg 2001; 27: 441-445.
13. Tsukamoto H, Hayashibe K, Mishima Y, Ichihashi M. The altered expression of α smooth muscle actin in basal cell epithelioma and its surrounding stroma: with special reference to proliferating cell antigen expression and adenoid differentiation. Br J Dermatol 1994; 130: 189-194.
14. De Rosa G, Barra E, Guarino M, Staibano S, Donofrio V, Boscaino A. Fibronectin, laminin, type IV collagen distribution, and myofibroblastic stromal reaction in aggressive and non-aggressive basal cell carcinoma. Am J Dermatopathol 1994; 16: 258-267.
15. Ramdial PK, Madaree A, Reddy R, Chetty R. Bcl-2 protein expression in aggressive and non-aggressive basal cell carcinoma. J Cutan Pathol 2000; 27: 283-291.
16. Crowson AN, Magro CM, Kadin ME, Stranc M. Differential expression of the bcl-2 oncogene in human basal cell carcinoma. Hum Pathol 1996; 27: 355-359.
17. Staibano S, Lo Muzio L, Mezza E, Argenziano G, Tornillo L, Pannone G, et al. Prognostic value of apoptotic index in cutaneous basal cell carcinomas of head and neck. Oral Oncol 1999; 35: 541-547.
18. Delehedde M, Cho S, Sarkiss M, Brisbay S, Davies M, McDonnell TJ. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer 1999; 85: 1514-1522.
19. Cho S, Hahm J-H, Hong Y-S. Analysis of p53 and bax mutations, loss of heterozygosity, p53 and bcl-2 expression and apoptosis in basal cell carcinoma in Korean patients. Br J Dermatol 2001; 144: 841-848.
20. van den Oord JJ, Vandeghinste N, De Ley M, De Wolf-Peeters C. Bcl-2 expression in human melanocytes and melanocytic tumors. Am J Pathol 1994; 145: 294-300.
21. Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Nunez G, et al. Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 1995; 146: 1079-1088.
22. Taylor JK, Zhang QQ, Monia BP, Marcusson EG, Dean NM. Inhibition of bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene 1999; 18: 4495-4504.
23. Rosen K, Karabulut TA, Hou-Jensen K, Krag JG. Bax protein is not expressed in basal cell carcinomas. Br J Dermatol 1998; 139: 472-474.
24. Tomkova H, Fujimoto W, Arata J. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers. Eur J Dermatol 1998; 8: 256-260.
25. Looi LM. Localized amyloidosis in basal cell carcinoma. A pathologic study. Cancer 1983; 52: 1833-1836.
26. Hashimoto K, Brownstein MH. Localized amyloidosis in basal cell epitheliomas. Acta Derm Venereol 1973; 53: 331-339.
27. Olsen KE, Westermark P. Amyloid in basal cell carcinoma and seborrheic keratosis. Acta Derm Venereol 1994; 74: 273-275.
28. Eto H, Hashimoto K, Kobayashi H, Fukaya T, Matsumoto M, Sun T-T. Differential staining of cytoid bodies and skin-limited amyloids with monoclonal antikeratin antibodies. Am J Pathol 1984; 116: 473-481.